Recent publications · Crossref
5 total works indexed
- Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer
· 2015 · cited 7,897x
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
· 2015 · cited 7,001x
- Integrative analysis of 111 reference human epigenomes
· 2015 · cited 6,297x
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
· 2013 · cited 4,887x
- Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
· 2012 · cited 4,417x
via Crossref · CC0
Available in 8 languages
via Wikidata sitelinks · CC0